- Home
- NTZ vs ANTX Comparison
NTZ vs ANTX Comparison
Compare NTZ & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTZ
- ANTX
- Stock Information
- Founded
- NTZ 1959
- ANTX 2017
- Country
- NTZ Italy
- ANTX United States
- Employees
- NTZ N/A
- ANTX N/A
- Industry
- NTZ Home Furnishings
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- NTZ Consumer Discretionary
- ANTX Health Care
- Exchange
- NTZ Nasdaq
- ANTX Nasdaq
- Market Cap
- NTZ 29.4M
- ANTX 34.4M
- IPO Year
- NTZ 1993
- ANTX 2022
- Fundamental
- Price
- NTZ $2.67
- ANTX $1.14
- Analyst Decision
- NTZ
- ANTX Buy
- Analyst Count
- NTZ 0
- ANTX 2
- Target Price
- NTZ N/A
- ANTX $2.00
- AVG Volume (30 Days)
- NTZ 2.7K
- ANTX 93.8K
- Earning Date
- NTZ 04-13-2023
- ANTX 11-12-2025
- Dividend Yield
- NTZ N/A
- ANTX N/A
- EPS Growth
- NTZ N/A
- ANTX N/A
- EPS
- NTZ N/A
- ANTX N/A
- Revenue
- NTZ $337,653,480.00
- ANTX N/A
- Revenue This Year
- NTZ N/A
- ANTX N/A
- Revenue Next Year
- NTZ N/A
- ANTX N/A
- P/E Ratio
- NTZ N/A
- ANTX N/A
- Revenue Growth
- NTZ N/A
- ANTX N/A
- 52 Week Low
- NTZ $2.15
- ANTX $0.98
- 52 Week High
- NTZ $6.27
- ANTX $1.68
- Technical
- Relative Strength Index (RSI)
- NTZ 37.97
- ANTX 41.54
- Support Level
- NTZ $2.61
- ANTX $1.13
- Resistance Level
- NTZ $3.15
- ANTX $1.22
- Average True Range (ATR)
- NTZ 0.08
- ANTX 0.06
- MACD
- NTZ -0.03
- ANTX -0.01
- Stochastic Oscillator
- NTZ 9.38
- ANTX 10.53
About NTZ Natuzzi S.p.A.
Natuzzi SpA is an Italian firm that designs, manufactures, and sells contemporary and traditional leather and fabric-upholstered furniture. Its product portfolio includes sofas, loveseats, armchairs, sectional furniture, motion furniture and sofa beds, living room furnishings, and accessories. The company markets its products under several brands such as Natuzzi Italia, Private label, and Natuzzi Editions. Geographically, it derives a majority of its revenue from the United States of America and also has an international presence in Italy, Spain, the UK, China, and Other countries.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.